Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Deferred Taxes (2016 - 2025)

Mimedx (MDXG) has disclosed Deferred Taxes for 6 consecutive years, with -$2.1 million as the latest value for Q4 2025.

  • Quarterly Deferred Taxes rose 11.97% to -$2.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$8.7 million through Dec 2025, up 30.16% year-over-year, with the annual reading at -$8.7 million for FY2025, 30.16% up from the prior year.
  • Deferred Taxes hit -$2.1 million in Q4 2025 for Mimedx, up from -$5.8 million in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $37.8 million in Q4 2023 to a low of -$5.8 million in Q3 2025.
  • Historically, Deferred Taxes has averaged $1.8 million across 3 years, with a median of -$2.1 million in 2025.
  • Biggest five-year swings in Deferred Taxes: crashed 106.16% in 2024 and later soared 94.59% in 2025.
  • Year by year, Deferred Taxes stood at $37.8 million in 2023, then plummeted by 106.16% to -$2.3 million in 2024, then increased by 11.97% to -$2.1 million in 2025.
  • Business Quant data shows Deferred Taxes for MDXG at -$2.1 million in Q4 2025, -$5.8 million in Q3 2025, and -$287000.0 in Q2 2025.